Simple blood test could transform cancer monitoring
NCT ID NCT06367751
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether liquid biopsies—simple blood tests that detect tumor DNA—can be used during regular doctor visits for people with advanced solid tumors. Researchers will collect blood samples from 159 patients and measure ctDNA levels to see how often the test finds tumor DNA and whether it reveals treatable genetic changes. They will compare results to patients who did not receive the test to understand its real-world usefulness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ctDNA measurement (liquid biopsy blood test)
What this could lead to
If successful, this could show that liquid biopsies are a practical tool for monitoring advanced cancer and identifying treatable genetic changes without invasive tissue biopsies.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve outcomes. The test may not detect all tumors, and results may not always change patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Medical Oncology, University Hospital Basel
Basel, 4031, Switzerland